Searched for: in-biosketch:true
person:ninanp01
Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy
van Kammen, D P; Mann, L S; Sternberg, D E; Scheinin, M; Ninan, P T; Marder, S R; van Kammen, W B; Rieder, R O; Linnoila, M
Schizophrenic patients with high ventricle brain ratios and cortical brain atrophy, as shown by computerized tomography, had decreased spinal fluid concentrations of homovanillic acid and dopamine-beta-hydroxylase activity. These decreased cerebral spinal fluid concentrations in patients with brain atrophy support the proposal of disturbed noradrenaline and dopamine neurotransmission in a subgroup of schizophrenic patients.
PMID: 6133351
ISSN: 0036-8075
CID: 3532442
CSF prostaglandin levels in depressed and schizophrenic patients
Linnoila, M; Whorton, A R; Rubinow, D R; Cowdry, R W; Ninan, P T; Waters, R N
PMID: 6838321
ISSN: 0003-990x
CID: 3532522
Benzodiazepine receptor-mediated experimental "anxiety" in primates
Ninan, P T; Insel, T M; Cohen, R M; Cook, J M; Skolnick, P; Paul, S M
The ethyl ester of beta-carboline-3-carboxylic acid has a high affinity for benzodiazepine receptors in the brain. In the rhesus monkey this substance produces an acute behavioral syndrome characterized by dramatic elevations in heart rate, blood pressure, plasma cortisol, and catecholamines. The effects are blocked by benzodiazepines and the specific benzodiazepine receptor antagonist Ro 15-1788. The benzodiazepine receptor may consist of several subsites or functional domains that independently recognize agonist, antagonists, or "active" antagonists such as beta-carboline-3-carboxylic acid ethyl ester. These results suggest that the benzodiazepine receptor is involved in both the affective and physiological manifestations of anxiety, and that the administration of beta-carboxylic acid ethyl ester to monkeys may provide a reliable and reproducible animal model of human anxiety.
PMID: 6293059
ISSN: 0036-8075
CID: 3532502